Stoke Therapeutics, Inc. Operating Leases, Future Minimum Payments Due, Next Twelve Months
Stoke Therapeutics, Inc. (STOK) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $1.10 million as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2021-03-09
- 2020-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $1.10M.
- 2019-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $1.15M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2020-12-31 | $1.10M 10-K · filed 2021-03-09 |
| 2019-12-31 | $1.15M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |